|
Originally published In Press as doi:10.1074/jbc.M000511200 on April 20, 2000
J. Biol. Chem., Vol. 275, Issue 26, 19638-19644, June 30, 2000
Nitric Oxide Inhibits the Tumor Necrosis Factor -regulated
Endocytosis of Human Dendritic Cells in a Cyclic
GMP-dependent Way*
Clara
Paolucci §¶,
Patrizia
Rovere¶ ,
Céline
De Nadai §,
Angelo A.
Manfredi , and
Emilio
Clementi **
From the Department of Neuroscience-DIBIT and
Laboratory of Tumour Immunology, Gene Therapy Programme, San
Raffaele Scientific Institute, 20132 Milano, Italy, the
§ Consiglio Nazionale delle Ricerche Centre for Cellular and
Molecular Pharmacology, 20129 Milano, Italy, and the ** Department of
Pharmaco-Biology, University of Calabria, 87036 Rende, Italy
Tumor necrosis factor- (TNF )-induced
maturation of dendritic cells (DC), with down-regulation of their
endocytic ability, has been reported to be mediated by the accumulation
of the lipid messenger ceramide. We have now studied the effects and
mechanisms of action of NO on endocytosis, investigated with
fluorescein isothiocyanate-labeled dextran using human monocyte-derived
DC, both immature and after treatment with TNF . Exposure of DC to NO, released by either bystander phagocytes or NO donors, reversed the
inhibition of endocytosis induced by TNF . The intracellular accumulation of ceramide induced by TNF was also inhibited by NO. In
addition, NO was found to exert an inhibitory effect downstream of the
TNF -triggered ceramide accumulation, because NO donors reversed the
inhibition of endocytosis induced by the cell-permeant C2-ceramide. These effects of NO were mimicked by the
membrane-permeant cyclic GMP analogue, 8-Br cyclic GMP, and prevented
by inhibition of the soluble guanylyl cyclase. At variance with
rodents, the inducible isoform of the NO synthase was expressed neither
in immature human DC nor after cell treatment with TNF ,
interferon- , and lipopolysaccharide, suggesting that regulation of
these cells depends on exogenous NO. NO, working through cyclic GMP,
might therefore prolong the ability of human DC to internalize antigens at the site of inflammation and thus modulate the initial steps leading
to antigen-specific immune responses.
*
This work was supported by grants from the Italian
Association for Cancer Research (to E. C. and A. M.), Consiglio
Nazionale delle Ricerche, Target Project Biotechnology (to E. C.),
Ministero dell'Università e della Ricerca Scientifica e
Tecnologica, Cofinanziamento 99 (to E. C.), Schering-Plough Italia
(to E. C.), and Istituto Superiore di Sanità, Progetto
Tubercolosi and HIV (to A. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
These authors contributed equally to this work.

To whom correspondence should be addressed: DIBIT-Scientific
Institute San Raffaele, Via Olgettina 58, 20132 Milano, Italy. Tel.:
39-02-2643-4814; Fax: 39-02-2643-4813; E-mail:
clementi.emilio@hsr.it.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Ebeling, T. Lam, J. R. Gordon, M. D. Hollenberg, and H. Vliagoftis
Proteinase-Activated Receptor-2 Promotes Allergic Sensitization to an Inhaled Antigen through a TNF-Mediated Pathway
J. Immunol.,
September 1, 2007;
179(5):
2910 - 2917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Perrotta, L. Bizzozero, S. Falcone, P. Rovere-Querini, A. Prinetti, E. H. Schuchman, S. Sonnino, A. A. Manfredi, and E. Clementi
Nitric Oxide Boosts Chemoimmunotherapy via Inhibition of Acid Sphingomyelinase in a Mouse Model of Melanoma
Cancer Res.,
August 15, 2007;
67(16):
7559 - 7564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Falcone, E. Cocucci, P. Podini, T. Kirchhausen, E. Clementi, and J. Meldolesi
Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events
J. Cell Sci.,
November 15, 2006;
119(22):
4758 - 4769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Morita, T. Uchiyama, and T. Hori
Nitric Oxide Inhibits IFN-{alpha} Production of Human Plasmacytoid Dendritic Cells Partly via a Guanosine 3',5'-Cyclic Monophosphate-Dependent Pathway
J. Immunol.,
July 15, 2005;
175(2):
806 - 812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nisoli, S. Falcone, C. Tonello, V. Cozzi, L. Palomba, M. Fiorani, A. Pisconti, S. Brunelli, A. Cardile, M. Francolini, et al.
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
PNAS,
November 23, 2004;
101(47):
16507 - 16512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Falcone, C. Perrotta, C. De Palma, A. Pisconti, C. Sciorati, A. Capobianco, P. Rovere-Querini, A. A. Manfredi, and E. Clementi
Activation of Acid Sphingomyelinase and Its Inhibition by the Nitric Oxide/Cyclic Guanosine 3',5'-Monophosphate Pathway: Key Events in Escherichia coli-Elicited Apoptosis of Dendritic Cells
J. Immunol.,
October 1, 2004;
173(7):
4452 - 4463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Perrotta, S. Falcone, A. Capobianco, A. Camporeale, C. Sciorati, C. D. Palma, A. Pisconti, P. Rovere-Querini, M. Bellone, A. A. Manfredi, et al.
Nitric Oxide Confers Therapeutic Activity to Dendritic Cells in a Mouse Model of Melanoma
Cancer Res.,
June 1, 2004;
64(11):
3767 - 3771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Paolucci, S. E. Burastero, P. Rovere-Querini, C. De Palma, S. Falcone, C. Perrotta, A. Capobianco, A. A. Manfredi, and E. Clementi
Synergism of nitric oxide and maturation signals on human dendritic cells occurs through a cyclic GMP-dependent pathway
J. Leukoc. Biol.,
February 1, 2003;
73(2):
253 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|